Dementia Improved Support Association of Japan
About Clinical Trial of Kouka
Applications for clinical trials from overseas individuals have now closed.
Purpose
The number of the people living with dementia is increasing worldwide, and now more than ever a lot of individuals and their families are forced to shoulder heavy burdens.
We, Dementia Improved Association of Japan, hold the view that saving those people and families solely by national policies is very difficult.
In response to this problem, we produced Kouka: a supplement developed on the basis of the findings from Prof. Masao Mori’s 40 plus years’ microcirculation research in Japan.
Kouka contains an extract of reishi mushroom, a natural crude drug that regulates microcirculation, which is an essential physiological function to life.
Kouka was patented in Japan as a composition of matter to ameliorate cognitive dysfunctions (No.6382281), for its significant effect to improve the functions as demonstrated by academic researches.
We decided to start the trial aiming to disseminate Kouka as a hope that lights those living with dementia all around the world.
Report
The reports will be presented at the Microcirculation Laboratory and the Society of Restoration-of-Health Medicine, both headed by Prof. Masao Mori.
Before that, detailed reports and testimonials from participants will be published at the official website of the Dementia Improved Support Association of Japan (https://disajp.org/).
Participant’s name and other personal information will be strictly kept secret,
although we can make the name open under the agreement.
Cost required for participants
– Shipping fee
We will dispatch 3 batches as shown in the schedule below.
Each shipment costs 2500JPY via PayPal.
We will explain detailed payment method at a later date.
Schedule
1st batch : A month’s worth of Kouka is dispatched after we receive the application.
2nd batch : Another month’s worth is dispatched on the first day of the next month,
after we receive the report for the first 2 weeks.
3rd batch : The last month’s worth is dispatched on the first day of the subsequent month,
after we receive the report for the first month.
After those 3 submissions, participants are required to send us the other 2 reports written after 2 months and 3 months from the start of dosing.
The submissions will be sent via emails.
We would like the participants to strictly keep dosed without skipping.
All those who agree with the condition above are welcomed to this 3 month trial program of Kouka.
Thank you very much for your consideration.
About the contents of the questionnaire item
Please refer to the attached file
https://disajp.org/media/uploads/2020/02/PDF-About-Clinical-Trial-of-Kouka.pdf
PR : For overseas customers news [ DIS SHOP ]